中國的乳癌治療藥市場
市場調查報告書
商品編碼
81745

中國的乳癌治療藥市場

Breast Cancer Treatment Drug Markets in China

出版日期: | 出版商: Asia Market Information & Development Co. | 英文 256 Pages | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

中國的乳癌治療藥需求在過去十年急速擴大。一般預測今後五年,生產及需求都將順利成長。

本報告提供中國的經濟趨勢,投資環境,產業的發展,需求及供給,產業結構,市場流通管道及主要企業等相關詳細調查,加上過去的實際成果和長期預測等,為您概述為以下內容。

第1章 簡介

  • 本調查報告的範圍和方法論
  • 摘要整理

第2章 商務環境

  • 經濟展望
    • 主要的經濟指標
    • 工業生產量
    • 人口及人力資源
    • 來自海外的投資
    • 海外貿易
  • 金融及稅金的法規
    • 銀行制度及法規
    • 外匯
    • 稅金,關稅及海關

第3章 乳癌治療藥產業評估

  • 產業結構
  • 市場規模
  • 推動市場成長要素
  • 銷售量
  • 主要製造商的設備據點
  • 主要製造廠商的銷售量及市場佔有率
  • 勞動成本
  • 有潛在性的參與企業
  • 主要的經銷商
  • 主要的海外投資
  • 技術開發

第4章 乳癌治療藥的生產及需求

  • 概要
  • 銷售量
    • 化療劑
    • Paclitaxel
    • Fluoropyrimidines
    • 蒽環類抗生素
    • 標靶治療藥
    • 治療抗體
    • 小分子藥
    • Aromatase抑制劑(標靶治療藥)
    • 內分泌腺治療藥
    • 抗雌激素
    • 孕甾酮
    • Aromatase抑制劑(內分泌腺治療藥)
    • LH-RH
  • 進口
    • 化療劑
    • Paclitaxel
    • Fluoropyrimidines
    • 蒽環類抗生素
    • 標靶治療藥
    • 治療抗體
    • 小分子藥
    • Aromatase抑制劑(標靶治療藥)
    • 內分泌腺治療藥
    • 抗雌激素
    • 孕甾酮
    • Aromatase抑制劑(內分泌腺治療藥)
    • LH-RH
  • 價格趨勢

第5章 乳癌治療藥市場展望

  • 乳癌治療藥市場展望
  • 政府的法規
  • 健康保險產業概要
  • 消費者支出趨勢
  • 人口動態
  • 醫療保健產業趨勢
  • 醫院及病床
  • 醫生及出診

第6章 市場進入流通管道

  • 打入中國市場概要
    • 中國流通系統
    • 流通管道
    • 運輸及運輸基礎設施
    • 通訊
  • 打入中國市場
    • 對中國出口
    • 間接出口
    • 直接出口
    • 專利及聯盟製造
    • 中國內的組裝
    • 聯盟製造
    • 貿易許可
    • 投資
    • 資本聯盟
    • 合併企業
    • 完全外資企業

第7章 乳癌治療藥製造商目錄

  • 製造商簡介及目錄
  • 主要的終端用戶

圖表清單

Product Code: 822

China's demand for Breast Cancer Treatment Drug has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2012, 2017 and 2022) and long-term forecasts through 2027 and 2032 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. BREAST CANCER TREATMENT DRUG INDUSTRY ASSESSMENTS

  • Breast Cancer Treatment Drug Industry Structure
  • Market Size
  • Market Growth Driver
  • Breast Cancer Treatment Drug Sales Volume
  • Major Producer Facility Locations
  • Major Producers' Sales Volume and Market Share
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investments
  • Technology Development

IV. BREAST CANCER TREATMENT DRUG PRODUCTION AND DEMAND

  • Overview
  • Breast Cancer Treatment Drugs Sales Volume
  • Chemotherapeutic Drug
  • Paclitaxel
  • Fluoropyrimidines
  • Anthracycline Antibiotics
  • Targeted Therapy Drug
  • Therapertic Antibody
  • Small Molecules Drug
  • Aromatase Inhibitors (Targeted Therapy Drug)
  • Endocrine Therapy Drug
  • Anti-estrogens
  • Progesterone
  • Aromatase Inhibitors (Endocrine Therapy Drug)
  • LH-RH
  • Breast Cancer Treatment Drugs Import
  • Chemotherapeutic Drug
  • Paclitaxel
  • Fluoropyrimidines
  • Anthracycline Antibiotics
  • Targeted Therapy Drug
  • Therapertic Antibody
  • Small Molecules Drug
  • Aromatase Inhibitors (Targeted Therapy Drug)
  • Endocrine Therapy Drug
  • Anti-estrogens
  • Progesterone
  • Aromatase Inhibitors (Endocrine Therapy Drug)
  • LH-RH
  • Pricing Trend

V. BREAST CANCER TREATMENT DRUG MARKET OUTLOOK

  • Breast Cancer Treatment Drug Markets Outlook Overview Concrete Government Regulations
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

VI. MARKET ENTRY CHANNELS

  • China Market Entry Overview
  • China's Distribution System
  • Breast Cancer Treatment Drug Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China's Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises

VII. ANTIFREEZE & THAWING AGENT PRODUCER DIRECTORY

  • Breast Cancer Treatment Drug Producer Profiles and Directory

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. BREAST CANCER TREATMENT DRUG INDUSTRY ASSESSMENTS

  • Breast Cancer Treatment Drug Sales Volume
  • Major Producer Facility Locations
  • Major Breast Cancer Treatment Drug Producer Sales Volume and Market Share
  • Major Foreign Investments

IV. BREAST CANCER TREATMENT DRUG PRODUCTION AND DEMAND

  • Total Breast Cancer Treatment Drugs Sales Volume
  • Breast Cancer Treatment Drug Major Producer and Their Market Share
  • Chemotherapeutic Drug Major Producer and Their Market Share
  • Paclitaxel Major Producer and Their Market Share
  • Fluoropyrimidines Major Producer and Their Market Share
  • Anthracycline Antibiotics Major Producer and Their Market Share
  • Targeted Therapy Drug Major Producer and Their Market Share
  • Therapertic Antibody Major Producer and Their Market Share
  • Small Molecules Drug Major Producer and Their Market Share
  • Aromatase Inhibitors (Targeted Therapy Drug) Major Producer and Their Market Share
  • Endocrine Therapy Drug Major Producer and Their Market Share
  • Anti-estrogens Major Producer and Their Market Share
  • Progesterone Major Producer and Their Market Share
  • Aromatase Inhibitors (Endocrine Therapy Drug) Major Producer and Their Market Share
  • LH-RH Major Producer and Their Market Share
  • Breast Cancer Treatment Drugs Import

V. BREAST CANCER TREATMENT DRUG MARKET OUTLOOK

  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

  • Breast Cancer Treatment Drug Sales Volume

II. BUSINESS ENVIRONMENT

  • China's GDP and Growth Rate
  • Industrial Output by Ownership
  • China's Imports and Exports

III. ANTIFREEZE & THAWING AGENT INDUSTRY ASSESSMENTS

  • Chemotherapeutic Drug Sales Volume by Drugs Classification
  • Targeted Therapy Drug Sales Volume by Drugs Classification
  • Endocrine Therapy Drug Sales Volume by Drugs Classification
  • Breast Cancer Treatment Drug Sales Volume

IV. ANTIFREEZE & THAWING AGENT PRODUCTION AND DEMAND

  • Breast Cancer Treatment Drug Sales Volume
  • Chemotherapeutic Drug Sales Volume and Market Share
  • Chemotherapeutic Drug Sales Volume by Drugs Classification
  • Paclitaxel Sales Volume and Market Share
  • Fluoropyrimidines Sales Volume and Market Share
  • Anthracycline Antibiotics Sales Volume and Market Share
  • Targeted Therapy Drug Sales Volume and Market Share
  • Targeted Therapy Drug Sales Volume by Drugs Classification
  • Therapertic Antibody Sales Volume and Market Share
  • Small Molecules Drug Sales Volume and Market Share
  • Aromatase Inhibitors (Targeted Therapy Drug) Sales Volume and Market Share
  • Endocrine Therapy Drug Sales Volume and Market Share
  • Endocrine Therapy Sales Volume by Drugs Classification
  • Anti-estrogens Sales Volume and Market Share
  • Progesterone Sales Volume and Market Share
  • Aromatase Inhibitors (Endocrine Therapy Drug) Sales Volume and Market Share
  • LH-RH Sales Volume and Market Share
  • Breast Cancer Treatment Drugs Import
  • Chemotherapeutic Drug Import and Market Share
  • Chemotherapeutic Drug Import by Drugs Classification
  • Paclitaxel Import and Market Share
  • Fluoropyrimidines Import and Market Share
  • Anthracycline Antibiotics Import and Market Share
  • Targeted Therapy Drug Import and Market Share
  • Targeted Therapy Drug Import by Drugs Classification
  • Therapertic Antibody Import and Market Share
  • Small Molecules Drug Import and Market Share
  • Aromatase Inhibitors (Targeted Therapy Drug) Import and Market Share
  • Endocrine Therapy Drug Import and Market Share
  • Endocrine Therapy Drug Import by Drugs Classification
  • Anti-estrogens Import and Market Share
  • Progesterone Import and Market Share
  • Aromatase Inhibitors (Endocrine Therapy Drug) Import and Market Share
  • LH-RH Import and Market Share

V. BREAST CANCER TREATMENT DRUG MARKET OUTLOOK

  • Breast Cancer Treatment Drugs Demand by Market

VI. MARKETING STRATEGIES

  • China's Distribution Channel